Until the end of the 20th century, evidence of safety and efficacy was sufficient for the launch of a technology and the development of its market. With the advancement of new technologies with higher costs and a limited budget and diversified portfolio perspective, the healthcare sector is continually adapting as well as the need for drug / medical device manufacturers to be able to expand their operations globally.

In the present scenario, simply developing an innovative drug or device does not fulfil the purpose of Life Science companies. They must ensure that the drug/device reaches the end user as quickly and safely as possible. They must create real value for patients in need. It is essential to access marketplaces where the potential patient segment exists. However, marketplace access must be undertaken with caution to increase the scope of the business and serve the purpose of the life sciences.

Thus, to suppress this new market demand, the Life Sciences industry needed to reposition itself by creating the Market Access area in order to include professionals who build strategies and deliver messages of value to the multiple stakeholders of the institutional health market. In this way, our strategy aims to differentiate and position technology in front of the paying sources available in the market through assertive messages and communications in order to create a continuous flow in the standardization assistance journey.

The MAPESolutions team is comprised of experts from the pharmaceutical industry, former managers, policy experts from the public/private perspective and experienced strategists who will be in charge of communicating the value messages in order to meet the complex evidence requirements demanded and to anticipate the payer’s barriers to getting reimbursed, price, and access they want. Our team of Marketplace Access experts based on Health Technology Assessment best practices will develop robust, succinct, and compelling speeches to shape payer positioning and overcome any objections from the payer source.